Arthritis Consumer Experts (ACE) is conducting a National Survey on Self-Advocacy. Please support this initiative by sharing with your patients. The link below offers more information, including the survey link: Self Advocacy Survey […]
Updated Biosimilar Fact Sheet
June 24 Biosimilar-Fact-Sheet […]
Updated Recommendations From the Vaccine Clinical Advisory Group
The Vaccine Clinical Advisory Group has published updated Recommendations on Exceptions to Extended Dose Intervals for COVID-19 vaccines. Please note that this is not yet government policy. To review the entire report, click […]
New Feature on SADIE: The Exceptional Access Program Digital Assistant – Now With Delegates!
The Ministry of Health continues to modernize the Exceptional Access Program (EAP) and transition away from fax-based processes by December 31, 2021. As the next major step forward, you can now assign delegates in SADIE who can create and […]
Attestation Forms to Confirm Vaccine Eligibility Not Required
The Ministry of Health has communicated to all 34 public health units that attestation forms and doctors’ notes are not required to confirm vaccine eligibility. This is in response to the OMA advocating to the government that […]
Information for Switching Actemra IV Patients to Subcutaneous
The ORA has prepared an important communication piece to explain this matter. You may view it here: Important information for switching Actemra IV patients to subcutaneous […]
New MOH Email Information Service
New MOH Email Information Service The Ontario Claims Services Branch has introduced subscription services for physicians and other health-care providers to receive email communications starting this month. This is a new resource to […]
Actemra IV Supply Update
The following notice was posted by the CRA on April 7, 2021: Dear CRA members, We would like to provide an update on the current situation concerning ACTEMRA IV in Canada. The CRA has been monitoring stock levels […]
Updated Biosimilar Fact Sheet – New LU Codes
The Ministry recently issued new LU Codes for etanercept and adalimumab biosimilars, effective March 29, 2021. The ORA has updated its Biosimilar Fact Sheet to reflect these changes. To download the form, please […]
OMA COVID-19 Patient Assessment Tool For Physicians
The OMA has made available a patient assessment tool for physicians. To access this resource, please visit this link: OMA Covid-19 Patient Assessment Tool For Physicians (March 2021) […]
